| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/04/2010 | EP2213301A1 Immune response inducer |
| 08/04/2010 | EP2213300A1 Composition and method for treating cancer using herpes virus |
| 08/04/2010 | EP2213299A1 Virus-based vaccine composition having a protein with zinc finger pattern(s), method of preparing and using same |
| 08/04/2010 | EP2213298A2 Immunogenic compositions of staphylococcus epidermidis polypeptide and polynucleotide antigens |
| 08/04/2010 | EP2213297A1 Staphylococcus aureus antigenic polypeptides |
| 08/04/2010 | EP2213284A1 Preparation for application to body surface and preparation holding sheet for application to body surface |
| 08/04/2010 | EP2212416A1 Uses of a glycoprotein vi (gpvi) inhibitor |
| 08/04/2010 | EP2212353A1 Antibody fragments inhibiting hiv nef protein |
| 08/04/2010 | EP2212350A1 Therapeutic and diagnostic methods using tim-3 |
| 08/04/2010 | EP2212345A1 Poxviral oncolytic vectors |
| 08/04/2010 | EP2211913A2 Systemic administration of chlorotoxin agents for the diagnosis and treatment of tumors |
| 08/04/2010 | EP2211905A1 Inhibitors of caspase i-dependent cytokines in the treatment of neurodegenerative disorders |
| 08/04/2010 | EP2211904A2 Cd19 binding agents and uses thereof |
| 08/04/2010 | EP2211903A1 Antibodes to cll-1 |
| 08/04/2010 | EP2211902A1 Uses of anti-cd40 antibodies |
| 08/04/2010 | EP2211900A1 Bioactive copepod-compositions, processes for the production thereof, and use thereof to prevent or treat hosts infested by phylogenetically similar ectoparasites |
| 08/04/2010 | EP2211880A1 Treatment regime for proliferative disorders |
| 08/04/2010 | EP2211871A1 Method for inhibiting angiogenesis or for treatment of cancer |
| 08/04/2010 | EP1920778B1 Composition for treatment of uveitis |
| 08/04/2010 | EP1708746B1 Recombinant vaccine against japanese encephalitis virus [jev] infection and a method thereof |
| 08/04/2010 | EP1694360B1 Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases and organ transplant rejection |
| 08/04/2010 | EP1635863B1 Compositions to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes |
| 08/04/2010 | EP1587539B1 Antimicrobial composition for local use on mucosal membranes and skin |
| 08/04/2010 | EP1572931B1 Methods and compositions for modulating and detecting wisp activity |
| 08/04/2010 | EP1531862B1 Stabilized liquid anti-rsv antibody formulations |
| 08/04/2010 | EP1430134B1 Hdv nucleic acid molecules, fragments and applications thereof |
| 08/04/2010 | EP1185660B1 Porcine circovirus vaccine in recombinant poxvirus |
| 08/04/2010 | EP1032675B1 Attaching substances to micro-organisms |
| 08/04/2010 | CN1906302B Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS |
| 08/04/2010 | CN1896094B Use of angiotensin II receptors I immunogenic peptide section |
| 08/04/2010 | CN101796190A Novel viral vector for the expression of heterologous sequences |
| 08/04/2010 | CN101796074A Anti-notch1 NRR antibodies and methods using same |
| 08/04/2010 | CN101796073A Humanized antibodies against CXCR3 |
| 08/04/2010 | CN101795713A conjugate purification |
| 08/04/2010 | CN101795709A Multimeric multiepitope influenza vaccines |
| 08/04/2010 | CN101795708A Reduction of concomitant infections in pigs by the use of PCV2 antigen |
| 08/04/2010 | CN101795707A Compositions and methods for microbe storage and delivery |
| 08/04/2010 | CN101795706A Bordetella parapertussis-containing whole-cell vaccine composition |
| 08/04/2010 | CN101795705A intradermal hpv peptide vaccination |
| 08/04/2010 | CN101792759A Immune co-enhancing molecule prepared by genetic engineering and immunopotentiation application thereof |
| 08/04/2010 | CN101792750A Yolk antibody for resisting activity of alpha-glucosidase and antigen, preparation method and application thereof |
| 08/04/2010 | CN101792745A Expression and purification of influenza virus polymerase PA N-terminal polypeptide and crystal structure thereof |
| 08/04/2010 | CN101792744A Recombinant baculovirus expressing Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) immunogen gene and preparation method and application thereof |
| 08/04/2010 | CN101792743A Recombinant baculovirus expressing porcine circovirus type 2 (PCV-2) immunogen gene and preparation method and application thereof |
| 08/04/2010 | CN101792742A Recombinant baculovirus expressing IBDV (Infectious Bursal Disease Virus) immunogen gene and preparation method and application thereof |
| 08/04/2010 | CN101792741A Recombinant baculovirus expressing Japanese Encephalitis Virus (JEV) immunogen gene and preparation method and application thereof |
| 08/04/2010 | CN101792740A Recombinant baculovirus expressing Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) immunogen gene and preparation method and application thereof |
| 08/04/2010 | CN101792491A Recombinant adenovirus HIV vaccine based on multipleseries epi-position and preparation method thereof |
| 08/04/2010 | CN101791405A Method for preparing yolk immunoglobulin vaccine for resisting porphyromonas gingivalis |
| 08/04/2010 | CN101791404A Fish soaking vaccine immunity adjuvant and application and using method thereof |
| 08/04/2010 | CN101791403A Fish soaking vaccine combination adjuvant and application and using method thereof |
| 08/04/2010 | CN101791402A Single-component fish vaccine soaking immunologic adjuvant as well as application and use method thereof |
| 08/04/2010 | CN101791401A Fish soaking vaccine multiple-combination adjuvant and application and using method thereof |
| 08/04/2010 | CN101791400A Fish soaking vaccine specific immunity intensifier and application and using method thereof |
| 08/04/2010 | CN101791399A Water-containing liquid allergic reaction bacterin preparation for mouth mucosa drug administration |
| 08/04/2010 | CN101791398A Multivalent canine vaccines against leptospira bratislava and other pathogens |
| 08/04/2010 | CN101791397A Application of RNase III protein in staphylococcus aureus for preventing and treating staphylococcus aureus infection |
| 08/04/2010 | CN101081296B Method for preparing b type haemophilus influenzae capsular polysaccharide and united vaccines thereof |
| 08/03/2010 | US7767842 Organopyrophosphate, -pyrophosphonate and -pyrophosphoramidate derivatives such as 4-hydroxy-2-methylbut-2-enyl pyrophosphate, 5-hydroxy-3-methylpent-3-enyl pyrophosphonate, 4-hydroxy-2-methylbut-2-enyl pyrophosphoramidate; anticarcinogenic and antiallergen agents; autoimmune diseases; immunotherapy |
| 08/03/2010 | US7767800 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes |
| 08/03/2010 | US7767793 Monolconal antibody specific to single immunoglobulin and toll-interleukin-1 receptor domain (SIGIRR) for treatment of rheumatoid arthritis, osteoporosis and inflammatory bowel diseases |
| 08/03/2010 | US7767792 Monoclonal antibody specific to epidermal growth factor receptor for targeting tumors and treating cancer; tissue targeted therapy |
| 08/03/2010 | US7767658 Vaccine composition |
| 08/03/2010 | US7767653 Enhancement of immune response to vaccine by interferon alpha |
| 08/03/2010 | US7767456 Non-viral gene delivery system |
| 08/03/2010 | US7767451 Cultured feline fetal tissue generated in absence of mammalian polypeptides for use as bioreactor in production of inexpensive feline vaccine |
| 08/03/2010 | US7767449 Methods using modified vaccinia virus |
| 08/03/2010 | US7767417 Prenyl-electrostatic switch, and methods of use |
| 08/03/2010 | US7767398 Nucleotide sequences comprising mutation in untranslated coding region of ATP-gated ion channel (P2X7R) for use as tool in diagnosing psychological disorders |
| 08/03/2010 | US7767392 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents |
| 08/03/2010 | US7767212 compositions and vaccines comprising at least one Fel d1 antigen or fragment thereof are not only capable of inducing immune responses against Fel d1, and hereby in particular antibody responses, but are, furthermore, capable of desensitizing a patient suffering from cat allergy |
| 08/03/2010 | US7767211 S.aureus polypeptides |
| 08/03/2010 | US7767210 immunogenic composition, comprising an inactivated whole West Nile virus wherein the West Nile virus is at least one of a strain OK02 having ATCC Accession No. PTA-8079 and a strain OK03 having ATCC Accession No. PTA-8078 and a pharmaceutically acceptable carrier or excipient |
| 08/03/2010 | US7767209 Modified vaccinia virus Ankara (MVA) mutant and use thereof |
| 08/03/2010 | US7767208 Noninvasive vascular therapy |
| 08/03/2010 | US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 08/03/2010 | US7767205 Erythropoietin-producing hepatocellullar kinase (EPH) specific immunoglobulin for use in treatment and prevention of tumor, cancer and/or cell proliferative disorders |
| 08/03/2010 | US7767202 Modulation of systemic immune responses by transplantation of hematopoietic stem cells transduced with genes encoding antigens and antigen presenting cell regulatory molecules |
| 08/03/2010 | US7767197 Immunogen formulation comprising antigen, polymer and liquid vehicle for stimulation of an immune response when administered to a host |
| 08/03/2010 | CA2412183C Rtvp based compositions and methods for the treatment of prostate cancer |
| 08/03/2010 | CA2409432C Modified morbillivirus v proteins |
| 08/03/2010 | CA2401342C Human antibodies against eotaxin and their use |
| 08/03/2010 | CA2381047C Vaccine against hepatitis b virus and human papilloma virus |
| 08/03/2010 | CA2361949C Heparin, or heparin conjugate, islets of langerhans |
| 08/03/2010 | CA2359776C Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies |
| 08/03/2010 | CA2343399C Method of vaccination against hsv in human females |
| 08/03/2010 | CA2263106C Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin |
| 08/03/2010 | CA2262423C Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
| 08/03/2010 | CA2224777C New immunoregulatory protein lst-1 |
| 08/03/2010 | CA2188813C Angiostatin protein, nucleic acids encoding the same and methods of detection |
| 08/03/2010 | CA2164848C Interleukin-2 stimulated t lymphocyte cell death for the treatment of autoimmune diseases, allergic disorders, and graft rejection |
| 08/03/2010 | CA2133873C Tnf inhibitors |
| 07/29/2010 | WO2010085648A2 Methods for reducing radiation-induced tissue damage |
| 07/29/2010 | WO2010085643A1 Targeting il-7 signaling as a therapy for multiple sclerosis and other il-7 signaling dependent disorders |
| 07/29/2010 | WO2010085611A2 Mycoplasma gallisepticum formulation |
| 07/29/2010 | WO2010085588A2 Modulating angiogenesis |
| 07/29/2010 | WO2010085510A1 Antibody mediated osseous regeneration |
| 07/29/2010 | WO2010085509A1 Compositions and methods for induction of antigen-specific tolerance |
| 07/29/2010 | WO2010085462A1 Method for treating triple negative breast cancer |
| 07/29/2010 | WO2010085371A2 Systems and methods to facilitate electronic payments |